回肠造口还纳术中预防性使用生物合成补片预防切口疝的意大利预算影响分析
该研究构建5年预算影响模型,比较回肠造口还纳术中预防性使用生物合成补片(5-25%递增使用率)与标准护理(无补片)在意大利的预算影响。
要点
- 补片策略在医院、国家卫生服务和社会角度均节省成本。
- 短期结果支持在高风险患者中选择性使用补片。
核心结论
- 回肠造口还纳术中预防性使用生物合成补片似乎可节省成本,减少造口部位切口疝和再干预。
- 短期结果支持在高风险患者中选择性使用补片,但长期生活质量获益仍不确定。
研究设计与样本
- 构建5年时间跨度的预算影响模型,比较标准护理(无补片)与预防性补片使用率递增(5-25%)的场景。
- 成本包括医院微观成本数据、国家疾病诊断相关组(DRG) tariffs和患者生产力损失。
主要发现
- 从医院角度,排除两种策略共有的手术室和医护人员成本后,补片组每患者成本为1,428.93€,无补片组为2,290.00€,节省861.07€。
- 从国家卫生服务角度每患者节省179.84€,从社会角度每患者节省328.45€。
- 情景分析证实节省效果在不同欧洲成本结构下保持一致。
关键数值与推荐
- 医院角度每患者成本:补片组1,428.93€,无补片组2,290.00€,节省861.07€。
- 国家卫生服务角度每患者节省179.84€,社会角度每患者节省328.45€。
临床怎么用
- 可考虑在高风险患者回肠造口还纳术中预防性使用生物合成补片以降低切口疝并节省成本。
- 研究结果可为卫生政策和未来卫生技术评估提供参考。
局限性
- 长期生活质量获益仍不确定。
- 临床效果基于一项前瞻性观察研究,而非随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stoma-site incisional hernia is a frequent complication after stoma closure, causing morbidity and health care burden. Prophylactic mesh reinforcement, particularly with biosynthetic meshes, has shown promise in reducing these hernias without increasing the risk for infection. This study aimed to assess the budget effects of using biosynthetic mesh prophylactically during ileostomy closure for hernia prevention, from hospital, National Healthcare Service, and societal perspectives in the Italian health care context. METHODS: A budget impact model was developed over a 5-year time period to compare standard care (no mesh) with increasing adoption of prophylactic mesh (5-25%). Costs included hospital micro-costing data, national diagnosis-related group tariffs, and patient productivity losses. Clinical effectiveness referred to a prospective observational study showing a significant reduction in stoma-site incisional hernia incidence with mesh (8 vs. 24%, P = .029). RESULTS: From the hospital perspective, excluding costs that are common to both strategies for operating room and health care personnel, per-patient costs were 1,428.93€ with mesh and 2,290.00€ without mesh (saving 861.07€). Savings were also observed from the National Healthcare Service (179.84€ per patient) and societal (328.45€ per patient) perspectives. At a national level, considering 4,000 ileostomy closures per year, increasing mesh uptake to 25% projected cumulative savings of about €1.32 million (hospital), €0.44 million (National Healthcare Service), and €0.89 million (society). Scenario analysis confirmed consistency of savings across various European cost structures. CONCLUSIONS: Prophylactic biosynthetic mesh during stoma closure appears cost-saving, reducing stoma-site incisional hernia and reinterventions. Although long-term quality-of-life benefits remain uncertain, short-term outcomes support selective use in high-risk patients. Findings may inform health policy and future health technology assessment processes.
引用
- Rognoni C, Bracale U, Peltrini R, et al. Preventing incisional hernia after ileostomy closure: Budget impact analysis of prophylactic biosynthetic mesh use in Italy. Surgery. 2026. PMID: 41924795. doi:10.1016/j.surg.2026.110175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。